{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:58:26Z","timestamp":1789995506868,"version":"4.0.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.amjcard.2004.04.024","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T14:53:45Z","timestamp":1090594425000},"page":"306-311","source":"Crossref","is-referenced-by-count":40,"title":["Safety and compliance with once-daily niacin extended-release\/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study"],"prefix":"10.1016","volume":"94","author":[{"given":"Melvyn","family":"Rubenfire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2004.04.024_BIB1","first-page":"869","article-title":"Effect of patient education on adherence to drug treatment for rheumatoid arthritis","volume":"60","author":"Hill","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/109019819001700303","article-title":"A patient education program to improve adherence rates with antituberculosis drug regimens","volume":"17","author":"Morisky","year":"1990","journal-title":"Health Educ Q"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB3","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archinte.1991.00400010067008","article-title":"Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia","volume":"151","author":"Bradford","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0002-9149(94)90307-7","article-title":"Expanded Clinical Evaluation of Lovastatin (EXCEL) study results","volume":"74","author":"Bradford","year":"1994","journal-title":"Am J Cardiol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2004.04.024_BIB6","doi-asserted-by":"crossref","first-page":"74U","DOI":"10.1016\/S0002-9149(98)00731-0","article-title":"Efficacy and safety of an extended-release niacin (Niaspan)","volume":"82","author":"Capuzzi","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0002-9149(00)00703-7","article-title":"Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia","volume":"85","author":"Goldberg","year":"2000","journal-title":"Am J Cardiol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2004.04.024_BIB8","doi-asserted-by":"crossref","first-page":"35U","DOI":"10.1016\/S0002-9149(98)00952-7","article-title":"Clinical trial experience with extended-release niacin (Niaspan)","volume":"82","author":"Goldberg","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/107424849600100302","article-title":"Treatment effect of Niaspan, a controlled-release niacin, in patients with hypercholesterolemia","volume":"1","author":"Morgan","year":"1996","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0026-0495(98)90284-0","article-title":"Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia","volume":"47","author":"Knopp","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB11","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.284.10.1263","article-title":"Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease. The ADMIT study","volume":"284","author":"Elam","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB12","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archinte.162.14.1568","article-title":"Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes","volume":"162","author":"Grundy","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB13","unstructured":"Adams PF, Benson V. Current Estimates from the National Health Interview Survey, 1991. Hyattsville, MD: US Department of Health and Human Services, 1992:1\u2013239"},{"key":"10.1016\/j.amjcard.2004.04.024_BIB14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.31.6.1206","article-title":"Conference report on stroke mortality in the southeastern United States","volume":"31","author":"Perry","year":"1998","journal-title":"Hypertension"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914904006101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914904006101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T13:46:32Z","timestamp":1624542392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914904006101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0002914904006101"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2004.04.024","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}